Hospital
Catholic Health Initiatives Colorado
Catholic Health Initiatives Colorado was paid $6.39M by Medicaid between Jan 2018 and Dec 2024, across 86 billing codes. Its largest line is 99283, emergency room visit (moderate) — 38% of everything it billed.
33Billing provider infoCATHOLIC HEALTH INITIATIVES COLORADO
CANON CITY, CO 81212
CANON CITY, CO 81212
33aNPI1922012350assigned 07/29/2006
33bProvider typeCritical Access Hospital
28Total paid$6.39M
24GClaims134,987
24DCodes billed86
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Critical Access Hospital providers in Colorado
Rank by total paid#1 of 26
Median peer was paid$111K
This provider vs. median58×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official RICHERT, TADD controls 16+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 18,443 | $755K | |
| 2019 | 14,923 | $747K | |
| 2020 | 12,545 | $579K | |
| 2021 | 18,683 | $811K | |
| 2022 | 18,369 | $1.02M | |
| 2023 | 29,601 | $1.42M | |
| 2024incomplete | 22,423 | $1.07M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 38% | 16,863 | 15,431 | $2.45M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 16% | 6,438 | 5,809 | $1.04M |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 11% | 5,470 | 5,003 | $734K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 10.0% | 2,061 | 1,780 | $638K |
| 96361 | Intravenous infusion, hydration; each additional hour | 9.0% | 1,824 | 1,638 | $577K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 4.4% | 2,069 | 1,890 | $279K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 2.5% | 5,204 | 1,442 | $160K |
| 80053 | Comprehensive metabolic panel | 2.4% | 11,471 | 10,337 | $152K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 621 | 610 | $50K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 522 | 485 | $39K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 109 | 100 | $35K |
| 64721 | <1% | 32 | 29 | $32K |
74 more codes
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 360 | $30K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 169 | $30K |
| 83605 | <1% | 1,426 | $21K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 1,969 | $15K |
| 84484 | <1% | 1,318 | $14K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,320 | $14K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 910 | $13K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 44 | $9K |
| 76830 | Ultrasound, transvaginal | <1% | 55 | $8K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 40 | $7K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 2,812 | $5K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 16 | $5K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 75 | $4K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 7,077 | $4K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 27 | $4K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 49 | $3K |
| G0378 | Hospital observation service, per hour | <1% | 26 | $3K |
| 87400 | <1% | 82 | $2K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 14 | $1K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 12 | $1K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 3,853 | $1K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 5,115 | $1K |
| 80047 | <1% | 44 | $1K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 17,105 | $1K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 625 | $961.93 |
| 87420 | <1% | 14 | $904.86 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 350 | $883.85 |
| 81001 | <1% | 2,160 | $671.70 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,806 | $533.85 |
| 71045 | Radiologic examination, chest; single view | <1% | 1,348 | $361.26 |
| 80076 | <1% | 16 | $352.41 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 3,741 | $309.14 |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | <1% | 18 | $235.48 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 651 | $226.96 |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 114 | $173.57 |
| 97161 | <1% | 14 | $151.95 | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 291 | $140.38 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 711 | $128.57 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 780 | $90.00 |
| 81003 | <1% | 232 | $88.04 | |
| J2704 | Injection, propofol, 10 mg | <1% | 2,583 | $79.87 |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 187 | $63.91 |
| 83690 | <1% | 813 | $42.85 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,637 | $42.25 |
| 81025 | <1% | 75 | $28.68 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,465 | $28.46 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 113 | $28.02 |
| 82077 | <1% | 78 | $16.23 | |
| 85610 | <1% | 12 | $2.58 | |
| J3490 | Unclassified drugs | <1% | 14,612 | $1.77 |
| 85014 | 0% | 29 | $0.00 | |
| 0753T | 0% | 17 | $0.00 | |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 0% | 63 | $0.00 |
| 82565 | 0% | 68 | $0.00 | |
| 0752T | 0% | 13 | $0.00 | |
| 82947 | 0% | 67 | $0.00 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 0% | 13 | $0.00 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 0% | 14 | $0.00 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 0% | 30 | $0.00 |
| 84540 | 0% | 86 | $0.00 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 921 | $0.00 |
| 85018 | 0% | 30 | $0.00 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 1,481 | $0.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 714 | $0.00 |
| 80051 | 0% | 68 | $0.00 | |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 0% | 56 | $0.00 |
| 88304 | 0% | 13 | $0.00 | |
| 82330 | 0% | 86 | $0.00 | |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 0% | 48 | $0.00 |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 0% | 13 | $0.00 |
| 84443 | Thyroid stimulating hormone (TSH) | 0% | 57 | $0.00 |
| 83735 | 0% | 19 | $0.00 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 0% | 14 | $0.00 |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 0% | 19 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialRICHERT, TADD (GROUP VP FINANCE)
Parent organizationCATHOLIC HEALTH INITIATIVES
| Provider | Location | Paid |
|---|---|---|
| Catholic Health Initiatives Colorado | Colorado Springs, CO | $25.26M |
| Catholic Health Initiatives Colorado | Pueblo, CO | $23.66M |
| Catholic Health Initiatives Colorado | Lakewood, CO | $8.91M |
| Catholic Health Initiatives Colorado | Canon City, CO | $8.35M |
| Catholic Health Iniatives Colorado | Westminster, CO | $7.55M |
| Catholic Health Initiatives Colorado | Durango, CO | $5.98M |
| Longmont United Hospital | Longmont, CO | $5.25M |
| Catholic Health Initiatives Colorado | Lakewood, CO | $4.40M |
| Commonspirit Kansas, INC. | Ulysses, KS | $2.77M |
| Commonspirit Kansas, INC. | Garden City, KS | $1.22M |
| Catholic Health Initiatives Colorado | Fort Morgan, CO | $1.17M |
| Catholic Health Iniatives Colorado | Frisco, CO | $691K |
| ST. Vincent Infirmary Medical Center | Sherwood, AR | $469K |
| Commonspirit Kansas, INC. | Dodge City, KS | $267K |
| Catholic Health Initiatives Colorado | Pueblo, CO | $153K |
| Catholic Health Initiatives Colorado | Colorado Springs, CO | $0.00 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.